Consistent with our in silico data analysis, functional experiments were performed using several established GBM-derived cell lines in which high expression of G6PC3, SLC37A2, and SLC37A4 in comparison to HepG2 hepatoma cells was observed. This evidence concerns the gene G6PC3 and glioblastoma.